Scarica l'app Stockscreener
13.37
0.00%
0.015
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Organon Co Borsa (OGN) Ultime notizie
Bonds, Loans and a Bold Leap: Inside Sun Pharma's Plan to Finance $12-Bn Organon Deal - outlookbusiness.com
Sun Pharma Evaluates Financing Plans for $12 Billion Organon Deal Acquisition - Siliconindia
Sun Pharma explores funding mix for $12 billion Organon deal - The Economic Times
Sun Pharma Explores Funding Mix for $12 Billion Organon Deal - Bloomberg.com
Halper Sadeh LLC is Investigating Whether MKC, LEG, OGN, KW are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN
Shanghvi’s audacious bet with $11.75-billion Sun-Organon deal - Fortune India
Sun Pharma to acquire Organon for $11.75bn - MSN
Sun Pharma Organon Deal: Indian Pharma King Ne Kar Liya $11.75B Ka Acquisition! Par Debt Ka Risk Kitna? - Whalesbook
A $12 billion US deal pushes Sun Pharma into big leagues - Moneycontrol.com
Are OGN, TBRG, CYCN Obtaining Fair Deals for their Shareholders? - marketscreener.com
Organon & Co. Reports Q1 2026 Financial Results: Revenue, Net Income, and Key Disclosures from Latest 10-Q Filing - Minichart
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Why Organon will need Dilip Shanghvi’s masterstroke - The Economic Times
Organon & Co. 1Q 2026: Revenue $1.46B, EPS $0.55— 10-Q Summary - TradingView
Sun Pharma to acquire Organon (NYSE: OGN) for $14 per share in cash - Stock Titan
Organon & Co is the best performing healthcare stock in April (XLV:NYSEARCA) - Seeking Alpha
Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more - MSN
India's biggest pharma deal: Sun Pharma to acquire US-based Organon in $11.75 billion deal - Business Standard
Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma - MSN
Sun Pharma's $11.75B Organon Buy: Speciality Drugs, Global Expansion & More - Deccan Herald
India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN
Sun Pharma exploring Eurobonds, bond swaps to fund US-based Organon buy - Business Standard
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Mitsubishi UFJ Trust & Banking Corp Sells 202,370 Shares of Organon & Co. $OGN - MarketBeat
Sun Pharma shares jump 9% as $11.75‑billion Organon buy seals entry into biosimilars, deal expected to close in 2027 - MSN
Sun Pharma shares jump 7% as India's largest drugmaker to buy US firm Organon in $11.75 billion deal - MSN
Organon Buyout And POHERDY Approval Shape Returns And Valuation Outlook - simplywall.st
MSN Money - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
The Sun Pharma-Organon deal, UAE’s divorce from OPEC, and more… - Finshots
Sun Pharma is marrying Organon - Finshots
Organon & Co. (NYSE:OGN) Short Interest Update - MarketBeat
Organon (OGN)’s Investors React Strongly as Sun Pharma Bets Big on Specialty Drug Expansion - Insider Monkey
OGN News Today | Why did Organon & Co. stock go up today? $OGN - MarketBeat
Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Organon & Co To Go Ex-Dividend On May 11th, 2026 With 0.02 USD Dividend Per Share - Moomoo
Organon (OGN) Margin Hit To 3% Tests Bullish Earnings Recovery Story - simplywall.st
Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates - StockStory
Organon & Co. (NYSE:OGN) Declares $0.02 Quarterly Dividend - MarketBeat
Sun Pharma To Acquire Former Merck Spinoff, Organon for $11.75 Bn - DCAT Value Chain Insights
Jim Cramer Says “Organon’s Done” Upon a Caller’s Inquiry - Insider Monkey
Vanguard Capital Management reports 13.7M shares in Organon (OGN) - Stock Titan
Organon Reports Results for the First Quarter Ended March 31, 2026 - BioSpace
Sun Pharma’s $11.75 billion Organon deal: not all brokers are hailing the high ROCE swap for leverage - Moneycontrol.com
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Organon (OGN) Q1 Earnings and Revenues Miss Estimates - Yahoo Finance
India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal - MSN
Earnings Flash (OGN) Organon & Co. Reports Q1 Revenue $1.46B, vs. FactSet Est of $1.49B - marketscreener.com
Earnings Flash (OGN) Organon & Co. Posts Q1 Adjusted EPS $0.71 per Share, vs. FactSet Est of $0.83 - marketscreener.com
Organon misses estimates as revenue declines 9% By Investing.com - Investing.com Canada
Organon (NYSE: OGN) Q1 2026 revenue dips as adjusted EPS falls - Stock Titan
Organon: Q1 Earnings Snapshot - marketscreener.com
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):